Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO

Stock Track04-18

Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.

The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.

Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1176686851?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-18 00:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1176686851","market":"sg","top_or_hot":-1,"title":"Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO","media":"Stock Track","content":"<p>Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.</p><p>The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.</p><p>Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Alamar Biosciences Soars 32.94% in Intraday Trading on Strong Nasdaq Debut After Upsized IPO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-04-18 00:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.</p><p>The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.</p><p>Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ALMR","symbol_name":"Alamar Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1176686851","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1176686851","pubTimestamp":1776443855,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ALMR":"Alamar Biosciences, Inc."},"translate_title":"个股赛道|Alamar Biosciences在扩大IPO规模后在纳斯达克首次亮相表现强劲，盘中飙升32.94%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ALMR":1},"content_text":"Alamar Biosciences (ALMR) stock soared 32.94% during intraday trading on Friday, following its initial public offering on the Nasdaq.The proteomics company, which develops instruments to detect low-level protein biomarkers in blood, priced its upsized IPO at $17 per share, the high end of its marketed range. The offering was increased to 11.25 million shares from 9.375 million, raising approximately $191.3 million and giving the company an initial market capitalization topping $1.1 billion.Shares opened for trading significantly above the IPO price, indicating strong investor demand for the company's debut. The successful pricing and enthusiastic market reception for the new issue drove the sharp price appreciation intraday.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1176686851","isCrawlerRequest":true}